BWC0977   Click here for help

GtoPdb Ligand ID: 12809

Compound class: Synthetic organic
Comment: BWC0977 is an oxazolidinone class antibacterial claimed in patent WO2018225097A1 [1]. It has broad-spectrum antibacterial activity and is a type II DNA topoisomerase inhibitor with similar activity against DNA gyrase and DNA topoisomerase 4.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 124.93
Molecular weight 468.44
XLogP -1.79
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN1C(=O)C=CC2=C1C(=C(C=C2)F)CCNC[C@@H]3CN(C4=NC5=C(N=C4)OCC(=O)N5)C(=O)O3
Isomeric SMILES CN1C(=O)C=CC2=C1C(=C(C=C2)F)CCNC[C@@H]3CN(C4=CN=C5C(=N4)NC(=O)CO5)C(=O)O3
InChI InChI=1S/C22H21FN6O5/c1-28-18(31)5-3-12-2-4-15(23)14(19(12)28)6-7-24-8-13-10-29(22(32)34-13)16-9-25-21-20(26-16)27-17(30)11-33-21/h2-5,9,13,24H,6-8,10-11H2,1H3,(H,26,27,30)/t13-/m1/s1
InChI Key MKICNOUBIXXGPQ-CYBMUJFWSA-N
References
1. Mohamed SHP, Bharatham N, Katagihallimath N, Sharma S, Nandishaiah R, Ramachandran V, Venkataraman B. (2018)
Heterocyclic compounds useful as anti-bacterial agents and method for production thereof.
Patent number: WO2018225097A1. Assignee: Bugworks Research Inc.. Priority date: 08/06/2018. Publication date: 13/12/2018.